Literature DB >> 18175269

The sulfonamide group as a structural alert: A distorted story?

Dennis A Smith1, Rhys M Jones.   

Abstract

The sulfonamide group is widely used in medicinal chemistry and appears in many marketed drugs in a variety of forms. One class of drugs that contain this group has been termed the 'sulfonamide antibacterials'. These compounds are inhibitors of tetrahydropteroic acid synthetase. Sulfonamide antibacterials are derivatives of 4-aminobenzenesulfonamide, in which the sulfonamide moiety acts as an isostere of the carboxylic acid group of the natural substrate 4-aminobenzoic acid. The 4-amino group is essential for activity in this class of compounds. These drugs, however, can cause hypersensitivity and severe skin rash, toxicities which are now associated with the presence of the aniline structure (4-amino), although, historically, the class affect was referred to as 'sulfa allergy'. This class effect has also been wrongly associated with other sulfonamide-containing drugs in a number of cases, and has led to warnings and labels that are not scientifically correct. This review explains how this confusion arose and illustrates the scientific evidence indicating that the sulfonamide group is an essential and safe part of the medicinal chemist's arsenal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175269

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  11 in total

1.  Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.

Authors:  Ying Zhao; William R Shadrick; Miranda J Wallace; Yinan Wu; Elizabeth C Griffith; Jianjun Qi; Mi-Kyung Yun; Stephen W White; Richard E Lee
Journal:  Bioorg Med Chem Lett       Date:  2016-07-04       Impact factor: 2.823

2.  N-(1H-Indazol-5-yl)-4-meth-oxy-benzene-sulfonamide.

Authors:  Hakima Chicha; El Mostapha Rakib; Latifa Bouissane; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-26

3.  Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.

Authors:  Manas R Dikhit; Bidyut Purkait; Ruby Singh; Bikash Ranjan Sahoo; Ashish Kumar; Rajiv K Kar; Md Yousuf Ansari; Savita Saini; Kumar Abhishek; Ganesh C Sahoo; Sushmita Das; Pradeep Das
Journal:  Drug Des Devel Ther       Date:  2016-05-26       Impact factor: 4.162

4.  A magnetic porous organic polymer: catalytic application in the synthesis of hybrid pyridines with indole, triazole and sulfonamide moieties.

Authors:  Morteza Torabi; Meysam Yarie; Mohammad Ali Zolfigol; Saeid Azizian; Yanlong Gu
Journal:  RSC Adv       Date:  2022-03-21       Impact factor: 3.361

5.  N-(1-Allyl-1H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide hemihydrate.

Authors:  Hakima Chicha; El Mostapha Rakib; Detlef Geffken; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-28

Review 6.  Drug repurposing and human parasitic protozoan diseases.

Authors:  Katherine T Andrews; Gillian Fisher; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-03-24       Impact factor: 4.077

7.  Palladium(II)-Catalyzed Synthesis of Sulfinates from Boronic Acids and DABSO: A Redox-Neutral, Phosphine-Free Transformation.

Authors:  Alex S Deeming; Claire J Russell; Michael C Willis
Journal:  Angew Chem Int Ed Engl       Date:  2015-11-24       Impact factor: 15.336

8.  Cross-Coupling of Sodium Sulfinates with Aryl, Heteroaryl, and Vinyl Halides by Nickel/Photoredox Dual Catalysis.

Authors:  Huifeng Yue; Chen Zhu; Magnus Rueping
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-05       Impact factor: 15.336

9.  Visible-Light, Iodine-Promoted Formation of N-Sulfonyl Imines and N-Alkylsulfonamides from Aldehydes and Hypervalent Iodine Reagents.

Authors:  Megan D Hopkins; Zachary C Brandeburg; Andrew J Hanson; Angus A Lamar
Journal:  Molecules       Date:  2018-07-24       Impact factor: 4.411

10.  Multilayer 3D Chirality and Its Synthetic Assembly.

Authors:  Guanzhao Wu; Yangxue Liu; Zhen Yang; Nandakumar Katakam; Hossein Rouh; Sultan Ahmed; Daniel Unruh; Kazimierz Surowiec; Guigen Li
Journal:  Research (Wash D C)       Date:  2019-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.